GUARNERI, VALENTINA
GUARNERI, VALENTINA
Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG
High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC).
2001 Bengala, C; Pazzagli, I; Innocenti, F; Donati, S; Favre, C; Menconi, Mc; Greco, F; Danesi, R; Orlandini, C; Guarneri, Valentina; Del Tacca, M; Conte, Pierfranco
Rischio neoplastico post-trapianto
2001 C., Bengala; Guarneri, Valentina; I., Pazzagli
New combinations with epirubicin in advanced breast cancer.
2001 Conte, Pierfranco; Gennari, A; Landucci, E; Guarneri, Valentina; Donati, S; Salvadori, B; Bengala, C; Orlandini, C.
Epirubicin/taxane combinations in breast cancer: experience from several Italian trials
2001 Conte, Pierfranco; Gennari, A; Guarneri, Valentina; Landucci, E; Donati, S; Salvadori, B; Bengala, C; Orlandini, C; Baldini, E.
Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
2002 Gennari, A; Guarneri, Valentina; Landucci, E; Orlandini, C; Rondini, M; Salvadori, B; Ricci, S; Conte, Pierfranco
Outcomes of metastatic breast cancer patients older than 60 years treated with FEC or ET regimens: A retrospective analysis
2003 Gennari, A.; Guarneri, V.; Orlandini, C.; Salvadori, B.; Donati, S.; Rondini, M.; Ricci, S.; Landucci, E.; Conte, Pierfranco
High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
2003 Bengala, C; Danesi, R; Guarneri, Valentina; Pazzagli, I; Donati, S; Favre, C; Fogli, S; Biadi, O; Innocenti, F; Del Tacca, M; Mariani, M; Conte, Pierfranco
Le Cellule Staminali Mesenchimali: Aspetti Biologici ed Approcci Terapeutici
2004 M., Dominici; Guarneri, Valentina; L., Cafarelli; Conte, Pierfranco
Changes in survival and time to progression in metastatic breast cancer (MBC) patients enrolled into clinical trials from 1983 to 2001
2004 A., Gennari; Conte, Pierfranco; C., Orlandini; V., Guarneri; R., Rosso; P., Bruzzi; for the North West Oncology Group, Gono
Concomitant versus sequential administration of epirubicin and paclitaxel as first-line therapy in metastatic breast carcinoma - Results from the Gruppo Oncologico Nord Ovest randomized trial
2004 Conte, Pierfranco; Guarneri, Valentina; P., Bruzzi; T., Prochilo; B., Salvadori; A., Bolognesi; D., Aldrighetti; M., Venturini; R., Rosso; S., Mammoliti; F., Carnino; P., Giannessi; M., Costantini; A., Moyano; E., Baldini
Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years
2004 Guarneri, Valentina; Donati, S; Nicolini, M; Conte, Pierfranco
Safety of intravenous and oral bisphosphonates and compliance with dosing regimens
2004 Conte, Pierfranco; Guarneri, Valentina
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support
2004 Guarneri, Valentina; C., Bengala; C., Orlandini; A., Gennari; S., Donati; D., Campani; P., Collecchi; M., Maur; Conte, Pierfranco
The curability of breast cancer and the treatment of advanced disease
2004 Guarneri, Valentina; Conte, Pierfranco
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy
2004 A., Gennari; P., Bruzzi; C., Orlandini; B., Salvadori; S., Donati; E., Landucci; Guarneri, Valentina; M., Rondini; S., Ricci; Conte, Pierfranco
Primary chemotherapy with gemcitabine, epirubicin and taxol (GET) in operable breast cancer: a phase II study
2005 Conte, Pierfranco; S., Donati; A., Gennari; Guarneri, Valentina; C., Orlandini; M., Rondini; M., Roncella; L., Marini; P., Collecchi; P., Viacava; A. G., Naccarato; R., DEGLI ESPOSTI; S., Bonardi; A., Bottini; S., Saracchini; S., Tumolo; G., Gullo; A., Santoro; L., Crino
Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma
2005 C., Bengala; Guarneri, Valentina; E., Giovannetti; M., Lencioni; E., Fontana; V., Mey; A., Fontana; U., Boggi; M., Del Chiaro; R., Danesi; S., Ricci; F., Mosca; M., Del Tacca; Conte, Pierfranco
The Issue of Renal Safety of Zoledronic Acid from a Nephrologist's Point of View
2005 Balla, J.; Lugassy, G.; Berenson, J.; Jackson, G.; Conte, Pierfranco; Guarneri, Valentina; Body, Jj
In response to Jackson letter to the editor regarding safety of intravenous and oral bisphosphonates and compliance with dosing regimens
2005 Conte, Pierfranco; Guarneri, Valentina
Operable Breast Cancer: preliminary results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarkers evaluation
2005 Guarneri, Valentina; Frassoldati, A; Ficarra, G; Giovannelli, S; Borghi, F; Puglisi, F; Mansutti, M; Andreetta, C; Banna, G; Masci, G; Santoro, A; Boni, C; Bisagni, G; Michelotti, A; Crispino, S; Conte, Pierfranco